NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/09/2025
Back to search
Official data from USPTO
VENTILASTIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
10/10/2025
Trademark type
Word
Nice classes
5
Filing date
07/18/2014
Registration date
03/03/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/17/2021
Last transaction
10/10/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
BOULTON,KELLY F
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MEDA Pharma GmbH & Co. KG
Representatives
Mylan Inc. - Trademarks
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of diseases of the respiratory system
Publications
History of USPTO decisions and trademark events.
26 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/16/2023
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
09/04/2022
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/10/2022
INPC
INVALIDATION PROCESSED
08/09/2022
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
05/17/2022
C71T
CANCELLED SECTION 71
09/17/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/03/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
08/16/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/03/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/03/2018
GPNX
NOTIFICATION PROCESSED BY IB
06/05/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/15/2015
FIMP
FINAL DISPOSITION PROCESSED
05/15/2015
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
04/02/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2015
GPNX
NOTIFICATION PROCESSED BY IB
12/19/2014
PUBO
PUBLISHED FOR OPPOSITION
12/16/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/03/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/03/2014
NPUB
NOTICE OF PUBLICATION
11/26/2014
MAFR
APPLICATION FILING RECEIPT MAILED
11/11/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/10/2014
DOCK
ASSIGNED TO EXAMINER
11/07/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2014
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
10/30/2014
Continuous trademark protection
Get notified about every new filing that threatens VENTILASTIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.